JJDC

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

16 Mar 2026

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.

JJDC

- Life Sciences
1(12 months)
jnjinnovation.com/home
Update Information

More venture news

Undo
16 Jun 2026
Undo raises £28m in funding from Elsewhere Partners to help AI agents find the root cause of bugs in complex codebases
EquityDeveloper Tools
Optera
15 Jun 2026
Optera raises £3m in funding led by Future Planet Capital to track fast-moving objects in space with neuromorphic sensors
EquityDefence
Friday4:30
11 Jun 2026
Friday4:30 lands £335k in funding from Haatch for incident response software for food and drink brands
EquitySupply Chain

JJDC

Investment Portfolio

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

More venture news

Undo raises £28m in funding from Elsewhere Partners to help AI agents find the root cause of bugs in complex codebases

Optera raises £3m in funding led by Future Planet Capital to track fast-moving objects in space with neuromorphic sensors

Friday4:30 lands £335k in funding from Haatch for incident response software for food and drink brands